1-12 of 12
Alfonso J Tafur
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Elevated Thrombin Generation Biomarkers and Their Relevance with Decreased Thrombin Generation Potential in Patients with Pulmonary Embolism

Fakiha Siddiqui, Priya Ray, Amir Darki, Debra Hoppensteadt, Emily Krupa, Alfonso J. Tafur, Grigoris Gerotziafas, Jawed Fareed, Manuel Monreal
Journal: Blood
Blood (2022) 140 (Supplement 1): 11214–11215.
https://doi.org/10.1182/blood-2022-165790
Published: 2022
Journal Articles

Amplified Thrombo-Inflammatory Biomarkers in Pulmonary Embolism with Augmented Responses in Von-Willebrand Factor, Microparticles and Interleukin-6 in Patients with Cancer

Fakiha Siddiqui, Amir Darki, Debra Hoppensteadt, Alfonso J. Tafur, Grigoris Gerotziafas, Jawed Fareed, Manuel Monreal
Journal: Blood
Blood (2022) 140 (Supplement 1): 11211–11213.
https://doi.org/10.1182/blood-2022-165767
Published: 2022
Journal Articles

Fibrinolytic Dysregulation Contributes to the Hypercoagulable State in Pulmonary Embolism Patients

Fakiha Siddiqui, Amir Darki, Emily Bontekoe, Yevgeniy Brailovsky, Omer Iqbal, Debra Hoppensteadt, Bulent Kantarcioglu, Alfonso J Tafur, Jawed Fareed
Journal: Blood
Blood (2021) 138 (Supplement 1): 3177.
https://doi.org/10.1182/blood-2021-153380
Published: 2021
Journal Articles

Assay Dependent Reversal of the Oral and Parenteral Anti-Xa Agents By Andexanet Alfa

Fakiha Siddiqui, Debra Hoppensteadt, PhD, Jeanine Walenga, PhD, Walter Jeske, PhD, Alfonso J Tafur, MD MS, Eduardo Ramacciotti, PhD MD, Jawed Fareed, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 39–40.
https://doi.org/10.1182/blood-2020-142653
Published: 2020
Journal Articles

Prothrombinase Induced Clotting Time Is More Sensitive then aPTT and PT and Can be Used for the Monitoring of Anti-Xa Agents in Whole Blood and Plasma

Debra Hoppensteadt, PhD, Emily Bontekoe, Fakiha Siddiqui, Ambar Farooqui, Omer Iqbal, MD, Walter Jeske, PhD, Jeanine Walenga, PhD, Alfonso J Tafur, MD MS, Jawed Fareed, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3374.
https://doi.org/10.1182/blood-2019-131221
Published: 2019
Journal Articles

Andexanet Alpha Differentially Neutralizes the Anticoagulant, Antiprotease and Thrombin Generation Inhibitory Effects of Unfractionated Heparin, Enoxaparin and Fondaparinux

Fakiha Siddiqui, Alfonso J Tafur, MD MS, Debra Hoppensteadt, PhD, Jeanine Walenga, PhD, Walter Jeske, PhD, Emily Bontekoe, Ahmed Kouta, Jawed Fareed, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1158.
https://doi.org/10.1182/blood-2019-127072
Published: 2019
Journal Articles

Differential Neutralization of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban By Andexanet Alfa As Measured By Whole Blood Thromboelastographic Analysis

Siddharth Mehrotra, Debra Hoppensteadt, PhD, Walter Jeske, PhD, Omer Iqbal, MD, Alfonso J Tafur, MD MS, Bruce Lewis, Jawed Fareed, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1155.
https://doi.org/10.1182/blood-2019-131907
Published: 2019
Journal Articles

Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study

Alfonso J Tafur, MD MS, Na Li, PhD, Nathan Clark, PharmD, Sam Schulman, MD PhD FRCPC, Alex Spyropoulos, MD, Joseph A Caprini, MD MS, FACS, RVT, James Douketis, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 710.
https://doi.org/10.1182/blood-2019-125292
Published: 2019
Journal Articles

Apixaban, Dalteparin, in Active Cancer Associated Venous Thromboembolism, the ADAM VTE Trial

Robert D. McBane, MD, Waldemar E. Wysokinski, MD PhD, Jennifer Le-Rademacher, PhD, Aneel A. Ashrani, MD, M.S., Alfonso J Tafur, MD MS, RPVI, FSVM, Krishna Gundabolu, MBBS, Juliana Perez-Botero, MD, Usha Perepu, MD, Daniel M. Anderson, MD MPH, Charles Kuzma, MD, Roberto leon Ferre, MD, Stanislav Henkin, MD, Charles Lenz, MD, Charles Loprinzi, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 421.
https://doi.org/10.1182/blood-2018-99-118808
Published: 2018
Journal Articles

Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study: A Perioperative Management Plan for Patients with Atrial Fibrillation Who Are Receiving a Direct Oral Anticoagulant

James Douketis, MD, Alex C. Spyropoulos, MD, Joanne M Duncan, MSc, Marc Carrier, MD, Gregoire Le Gal, MD PhD, Alfonso J Tafur, MD MS, RPVI, FSVM, Thomas Vanassche, MD, Peter Verhamme, MD PhD, Sudeep P Shivakumar, MD BSc, Peter L. Gross, MD, Agnes Yuet Ying Lee, MD MSc, FRCPC, Erik Yeo, MD FACP, FRCPC, Susan Solymoss, MD, Jeannine Kassis, MD, Genevieve Le Templier, Stephen Kowalski, MD, Mark Blostein, MD FRCPC, Vinay Shah, MD, Elizabeth MacKay, MD FRCPC, Cynthia M. Wu, MD FRCPC, Nathan Clark, PharmD, Shannon M. Bates, MD MSc, Fred Spencer, MD FRCP, Eleni Arnaoutoglou, MD, Michiel Coppens, MD, Donald M. Arnold, MD MSc, FRCPC, Joseph A Caprini, MD MS, FACS, RVT, Na Li, PhD, Karen Moffat, MT, Syed Summer, MD, Sam Schulman, MD PhD FRCPC
Journal: Blood
Blood (2018) 132 (Supplement 1): LBA-5.
https://doi.org/10.1182/blood-2018-120770
Published: 2018
Journal Articles

Development and Validation of a 30-Day Mortality Prediction Model for Patients with Cancer-Associated Thrombosis (CAT) in the Riete Database

Harry E Fuentes, MD MS, Alfonso J Tafur, MD MS, RPVI, FSVM, Joseph A Caprini, MD MS, FACS, RVT, Adriano Alatri, MD, Javier Trujillo-Santos, MD, Dominique Farge-Bancel, MD PhD, Monreal Manuel, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1094.
https://doi.org/10.1182/blood.V130.Suppl_1.1094.1094
Published: 2017
Journal Articles

Three-Month Cumulative Incidence of Thromboembolism and Bleeding After Periprocedural Anticoagulation Management of Patients with Active Cancer.

Alfonso J Tafur, M.D., Edyta Wolny, M.D., Ph.D., Robert McBane, II, M.D., Edyta Sutkowska, Joshua P Slusser, David O Hodge, MS, John A. Heit, Waldemar E Wysokinski, M.D., Ph.D.
Journal: Blood
Blood (2009) 114 (22): 491.
https://doi.org/10.1182/blood.V114.22.491.491
Published: 2009